Assessment of Factors Affecting Therapeutic Response of the DPP-4 Inhibitor Sitagliptin in A Sample of Iraqi Type 2 Diabetic Patients. (2024). Al Mustansiriyah Journal of Pharmaceutical Sciences, 24(3), 311-319. https://doi.org/10.32947/ajps.v24i3.1082